No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
RGEN250117P220000
- 37.90
- 0.000.00%
15min DelayClose Dec 20 16:00 ET
0.00High0.00Low
37.90Open37.90Pre Close0 Volume0 Open Interest220.00Strike Price0.00Turnover77.37%IV-26.06%PremiumJan 17, 2025Expiry Date75.54Intrinsic Value100Multiplier25DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9923Delta0.0030Gamma1.91Leverage Ratio-0.0062Theta-0.0169Rho-1.90Eff Leverage0.0069Vega
Intraday
- 5D
- Daily
News
Repligen Corporation (RGEN) Fell Along With Peers
Repligen Initiated at Hold by Canaccord Genuity
Repligen Analyst Ratings
CCORF Initiates Repligen(RGEN.US) With Hold Rating, Announces Target Price $165
Express News | BioLife Solutions Appoints Tony J. Hunt to Its Board of Directors
Press Release: BioLife Solutions Appoints Tony J. Hunt to Its Board of Directors